Chemotherapy and cystectomy for invasive transitional cell carcinoma of bladder

By Raghavan D.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 6, 2003-11 ,pp. : 468-474

Elsevier

Access to resources Recommend Favorite

HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy?

By Latif Z.   Watters A.D.   Dunn I.   Grigor K.   Underwood M.A.   Bartlett J.M.S.  

European Journal of Cancer, Vol. 40, Iss. 1, 2004-01 ,pp. : 56-63

Elsevier

Access to resources Recommend Favorite

Expression of brainspecific angiogenesis inhibitor1 and association with p53, microvessel density and vascular endothelial growth factor in the tissue of human bladder transitional cell carcinoma

By Tian Dawei   Hu Hailong   Sun Yan   Tang Yang   Lei Mingde   Liu Liwei   Han Ruifa   Wu Changli  

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-09 ,pp. : 4522-4529

Spandidos Publications

Access to resources Recommend Favorite

Long-term follow-up of g 3 t 1 transitional cell carcinoma of the bladder treated with intravesical bacille calmette-guerin: 18-year experience. - Urology 2002;59:227-231.

By Pansadoro V.   Emiliozzi P.   de Paula F.   Scarpone P.   Pansadoro A.   Sternberg G.N.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 2, 2003-03 ,pp. : 165-165

Elsevier

Access to resources Recommend Favorite

Clinical Signficance of p53, Proliferating Cell Nuclear Antigen and bcl-2 Expression in Bladder Transitional Cell Carcinoma

By Zhu Zhaohui   Cheng Ping   Zeng Fuqing   Lu Gongcheng   Xing Shian  

The Chinese-German Journal of Clinical Oncology, Vol. 3, Iss. 1, 2004-03 ,pp. : 20-23

Springer Publishing Company

Access to resources Recommend Favorite